BridgeMD
Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery (CRPS-VITC)
EU CTIS ID: 2024-518310-28-00
What this study is testing
The aim of the study is to demonstrate a significant reduction of CRPS 1 when taking vitamin C during the perioperative period in upper limb surgery.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- patients over 18 yo undergoing major surgery of the upper limb
- patients able to give their consent to follow the protocol of treatment and monitoring
- Patient with social security coverage
You likely can't join if
- Patient not wishing to be part of the study, or out of condition to express consent
- patients suffering or having already suffered from complex regional pain syndrome type 1 or type 2
- Patient seeking follow-up outside referral centres
- patients unable due to personal or professional mobility, to conduct post-operative follow up
- patients undergoing surgery with nerve suture with nerve graft
- Patient requiring two surgical procedures on the same limb
See the full eligibility criteria
- patients over 18 yo undergoing major surgery of the upper limb
- patients able to give their consent to follow the protocol of treatment and monitoring
- Patient with social security coverage
- Patient not wishing to be part of the study, or out of condition to express consent
- patients suffering or having already suffered from complex regional pain syndrome type 1 or type 2
- Patient seeking follow-up outside referral centres
- patients unable due to personal or professional mobility, to conduct post-operative follow up
- patients undergoing surgery with nerve suture with nerve graft
- Patient requiring two surgical procedures on the same limb
- emergency surgery
- children
- patients under guardianship
- Woman of childbearing potential without an effective contraceptive method
- pregnant or lactating women
- patients with hemochromatosis
- patients with chronic kidney disease
- patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency
- allergy or known hypersensitivity to one of the molecules of treatment
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.